Pearl, a medical technology company focusing on dental AI, has secured $58m in a Series B financing round to improve patient care in dentistry.
Co-founded in 2019 by Ophir Tanz, Cambron Carter, and Kyle Stanley, the company’s latest financing round is the largest-ever investment in dental artificial intelligence.
The round was spearheaded by Left Lane Capital, with a significant contribution from new investors Alpha Partners and Smash Capital, and existing investors Neotribe Ventures and Craft Ventures.
Pear will use the latest investments to advance innovative technologies aimed at enhancing the dental health of patients globally by expanding its product line with dental AI solutions and increasing global access to life-changing benefits of artificial intelligence in the field of dentistry.
Solving a Core Challenge in Dentistry
Pearl’s machine learning and computer vision technology enables dentists to achieve consistent diagnostic accuracy, which has long been a core problem in dentistry, directly improving the quality of patient care.
The AI tools provide real-time support, enabling dentists to analyze patients’ X-rays and deliver consistent, accurate, and objective diagnoses. It also helps dentists communicate medical findings to patients with clarity, precision, and confidence.
Since it received FDA approval for AI software designed to help dentists identify many different pathologies in X-rays, Pearl’s dental AI is authorized for bedside use in over 120 countries.
With the new capital, the company plans to accelerate the development of its computer vision capabilities to include 3D disease detection and tracking, among other imaging capabilities.